For the Inventor, By the Inventor

Enter assignee name

Baltimore, MD, United States of America

Nova Pharmaceutical Corporation

Calculating rank

USPTO Granted Patents = 23

Trademarks = 1

Forward Citations = 1,433

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Abraham J Domb (12 out of 42 patents)

Waclaw J Rzeszotarski (6 out of 17 patents)

Manoj Maniar (5 out of 8 patents)

4. Ronald M Burch (3 out of 3 patents)

5. Donald J Kyle (3 out of 16 patents)

6. John W Ferkany (2 out of 3 patents)

7. Maria E Guzewska (2 out of 5 patents)

8. Barry G Shearer (2 out of 2 patents)

9. Babu J Mavunkel (2 out of 2 patents)

10. Eyal S Ron (1 out of 35 patents)

11. Michael J Pontecorvo (1 out of 3 patents)

12. Mary E Abreu (1 out of 2 patents)

13. Roger N Hiner (1 out of 5 patents)

14. Richard L Elliott (1 out of 1 patent)

15. Lisa H Conti (1 out of 1 patent)

23 patents: Sort by Forward Citations

1. 5340588 - Liposphere carriers of vaccines (1994-08-23),

2. 5317079 - Fatty acid terminated polyanhydride (1994-05-31),

3. 5270419 - Polyanhydrides of oligomerized unsaturated aliphatic acids (1993-12-14),

4. 5240963 - Branched polyanhydrides (1993-08-31),

5. 5227165 - Liposphere delivery systems for local anesthetics (1993-07-13),

6. 5221535 - Sustained release formulations of insect repellent (1993-06-22),

7. 5189046 - Protein kinase C modulators (1993-02-23),

8. 5188837 - Lipsopheres for controlled delivery of substances (1993-02-23),

9. 5179189 - Fatty acid terminated polyanhydrides (1993-01-12),

10. 5175235 - Branched polyanhydrides (1992-12-29),

11. 5171812 - Polyanhydrides of oligomerized unsaturated aliphatic acids (1992-12-15),

12. 5135917 - Interleukin receptor expression inhibiting antisense oligonucleotides (1992-08-04),

13. 5122367 - Polyanhydride bioerodible controlled release implants for administration (1992-06-16),

14. 5079260 - Method for treating inflammation and compounds and compositions suitable (1992-01-07),

15. 5063245 - Corticotropin-releasing factor antagonism compounds (1991-11-05),

Company Overview

Nova Pharmaceutical Corporation, based in Baltimore, MD, specializes in the development and manufacturing of innovative pharmaceutical products. The company focuses on a range of therapeutic areas, including oncology, neurology, and infectious diseases, aiming to address unmet medical needs through advanced research and technology. With a commitment to quality and efficacy, Nova collaborates with healthcare professionals and institutions to enhance patient outcomes and contribute to the evolving landscape of modern medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

23 Patents

#23 in Baltimore, MD

#190 in Maryland

#14,466 in US

#27,777 in the World

Baltimore, MD, United States of America

Nova Pharmaceutical Corporation

Forward Citations = 1,433

23 inventors:

Abraham J Domb (12 out of 42 patents)

Waclaw J Rzeszotarski (6 out of 17 patents)

Manoj Maniar (5 out of 8 patents)

4. Ronald M Burch (3 out of 3 patents)

5. Donald J Kyle (3 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nova Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/nova-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…